209 related articles for article (PubMed ID: 31992208)
1. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
Kim H; Heo MH; Kim JY
BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.
Lim KH; Oh DY; Chie EK; Jang JY; Im SA; Kim TY; Kim SW; Ha SW; Bang YJ
BMC Cancer; 2009 Sep; 9():345. PubMed ID: 19781103
[TBL] [Abstract][Full Text] [Related]
3. Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer.
Yu JI; Lim DH; Lee J; Kang WK; Park SH; Park JO; Park YS; Lim HY; Kim ST; Lee SJ; Kim S; Sohn TS; Lee JH; An JY; Choi MG; Bae JM; Kim HS; Ahn S
Radiother Oncol; 2018 Nov; 129(2):306-312. PubMed ID: 30037498
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of salvage chemoradiotherapy for locally recurrent biliary tract cancer.
Il Yu J; Chul Park H; Hoon Lim D; Oh Park J; Suk Park Y; Tae Kim S; Ho Choi S; Wook Choi D; Woong Han I; Seok Heo J
Tumori; 2017 Jul; 103(4):345-352. PubMed ID: 28708225
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of S-1 Adjuvant Chemotherapy for Resected Biliary Tract Cancer: A Retrospective Propensity-Matched Analysis.
Yoshida M; Yanagimoto H; Tsugawa D; Akita M; Urade T; Nanno Y; Fukushima K; Gon H; Komatsu S; Asari S; Kido M; Toyama H; Ajiki T; Fukumoto T
Am Surg; 2024 Jun; 90(6):1279-1289. PubMed ID: 38226586
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
Gbolahan OB; Zhi X; Liu Y; Shah MM; Kooby DA; Alese OB
JAMA Netw Open; 2024 Jan; 7(1):e2351502. PubMed ID: 38206623
[TBL] [Abstract][Full Text] [Related]
9. The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.
Palloni A; Bisello S; Maggio I; Massucci M; Galuppi A; Di Federico A; Rizzo A; Ricci AD; Siepe G; Morganti AG; Brandi G; Frega G
Curr Oncol; 2023 May; 30(5):4754-4766. PubMed ID: 37232816
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
Lee J; Kang SH; Noh OK; Chun M; Oh YT; Kim BW; Kim SW
Clin Transl Oncol; 2018 Aug; 20(8):1011-1017. PubMed ID: 29256155
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes and the Role of Adjuvant Concurrent Chemoradiation Therapy in D2-resected LN-positive Young Patients (≤45 Years) With Gastric Cancer.
Yu JI; Lim DH; Lee J; Kang WK; Park SH; Park JO; Lim HY; Kim ST; Kim S; Sohn TS; Lee JH; An JY; Choi MG; Bae JM; Kim HS; Ahn S
Anticancer Res; 2019 Oct; 39(10):5811-5820. PubMed ID: 31570486
[TBL] [Abstract][Full Text] [Related]
12. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study.
Yin L; Xu Q; Li J; Wei Q; Ying J
Medicine (Baltimore); 2018 Dec; 97(50):e13570. PubMed ID: 30558021
[TBL] [Abstract][Full Text] [Related]
13. A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas.
Nesseler JP; Salleron J; Rios M; Nickers P; Marchal F; Brocard F; Peiffert D; Vogin G
Radiother Oncol; 2017 Oct; 125(1):160-167. PubMed ID: 28951009
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Setakornnukul J; Thephamongkhol K
BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
[TBL] [Abstract][Full Text] [Related]
16. Age as a modifier of the effects of chemoradiotherapy with infusional 5-fluorouracil after D2 dissection in gastric cancer.
Wu HC; Lin WL; Lin CL; Lin CY; Chen SW; Chen YX; Chen CH; Lee SW; Chen SH; Tsao CJ; Huang WT; Guo HR
Aging (Albany NY); 2021 Jul; 13(13):17337-17348. PubMed ID: 34226296
[TBL] [Abstract][Full Text] [Related]
17. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
[TBL] [Abstract][Full Text] [Related]
18. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
19. Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14).
Kim K; Yu JI; Jung W; Kim TH; Seong J; Kim WC; Choi JH; Park Y; Jeong BK; Kim BH; Kim TG; Kim JH; Park HJ; Shin HS; Im JH; Heo JS; Park JO; Jang JY; Oh DY; Woo SM; Lee WJ; Chie EK
Eur J Cancer; 2021 Nov; 157():31-39. PubMed ID: 34474218
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and network meta-analysis of adjuvant therapy for curatively resected biliary tract cancers.
Kish M; Chan K; Perry K; Ko YJ
Curr Oncol; 2020 Feb; 27(1):e20-e26. PubMed ID: 32218664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
